KMG Fiduciary Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-43,677
Closed -$2.65M 216
2026
Q1
$2.65M Buy
43,677
+527
+1% +$30.7K 0.2% 114
2025
Q4
$2.33M Buy
43,150
+592
+1% +$28.5K 0.17% 120
2025
Q3
$1.92M Buy
42,558
+1,194
+3% +$55.8K 0.13% 142
2025
Q2
$1.91M Buy
41,364
+1,961
+5% +$96.3K 0.14% 138
2025
Q1
$2.4M Buy
39,403
+4,193
+12% +$244K 0.2% 112
2024
Q4
$1.99M Buy
35,210
+4,144
+13% +$232K 0.16% 126
2024
Q3
$1.61M Buy
31,066
+618
+2% +$29K 0.14% 142
2024
Q2
$1.26M Buy
30,448
+2,944
+11% +$132K 0.12% 131
2024
Q1
$1.49M Buy
27,504
+1,092
+4% +$55.6K 0.15% 123
2023
Q4
$1.36M Sell
26,412
-4,767
-15% -$250K 0.16% 126
2023
Q3
$1.81M Sell
31,179
-1,699
-5% -$104K 0.24% 98
2023
Q2
$2.1M Buy
32,878
+73
+0.2% +$4.89K 0.27% 89
2023
Q1
$2.27M Buy
32,805
+1,424
+5% +$100K 0.33% 80
2022
Q4
$2.26M Buy
31,381
+3,683
+13% +$278K 0.37% 77
2022
Q3
$1.97M Sell
27,698
-4,647
-14% -$337K 0.38% 72
2022
Q2
$2.49M Buy
32,345
+421
+1% +$32.1K 0.46% 56
2022
Q1
$2.33M Buy
31,924
+4,411
+16% +$296K 0.37% 69
2021
Q4
$1.72M Sell
27,513
-1,907
-6% -$112K 0.27% 89
2021
Q3
$1.74M Sell
29,420
-1,068
-4% -$70.3K 0.3% 81
2021
Q2
$2.04M Buy
30,488
+988
+3% +$64.4K 0.36% 63
2021
Q1
$1.86M Buy
29,500
+4,589
+18% +$286K 0.36% 62
2020
Q4
$1.53M Buy
24,911
+3,618
+17% +$222K 0.32% 71
2020
Q3
$1.28M Buy
21,293
+6,319
+42% +$380K 0.32% 70
2020
Q2
$880K Buy
14,974
+7,506
+101% +$449K 0.24% 79
2020
Q1
$416K Buy
7,468
+1,136
+18% +$69.4K 0.14% 95
2019
Q4
$406K Buy
6,332
+1,312
+26% +$75.1K 0.12% 93
2019
Q3
$255K Hold
5,020
0.09% 102
2019
Q2
$228K Sell
5,020
-142
-3% -$6.61K 0.08% 101
2019
Q1
$246K Hold
5,162
0.09% 103
2018
Q4
$268K Buy
+5,162
New +$277K 0.12% 82

Other funds holding BMY